GA201: a novel humanized and glycoengineered anti-EGFR antibody--letter

Clin Cancer Res. 2014 Feb 15;20(4):1053-4. doi: 10.1158/1078-0432.CCR-13-2124.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antibody-Dependent Cell Cytotoxicity / drug effects*
  • Antineoplastic Agents / pharmacology*
  • ErbB Receptors / metabolism*
  • Female
  • Glycoproteins / pharmacology*
  • Humans
  • Metabolic Engineering*
  • Neoplasms / immunology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Glycoproteins
  • ErbB Receptors